glp-1 ra drugs list Mapping the effectiveness and risks of receptor agonists The Boom in New Weight

However, there is a growing interest in using Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) in PCOS due to their efficacy in weight loss, insulin resistance, and heart health

EP-3972630-A1

and collaborate across the wider GLP-1 ecosystem to better serve customers. PwC estimates that the availability of the drug in pill form on the UK market could see users increase from around 3 million to 7 million, equating to roughly 13% of UK adults.

Scientists at the 23andMe Research Institute published a study in Nature that has identified genetic variants associated with weight loss and side effects among those who have taken GLP-1 medications